Is a complete INAB research report available?

No complete published report is available for IN8bio, Inc. (INAB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

IN8bio, Inc. (INAB)

NASDAQ: INAB · USD

$1.08

+0.01 (+0.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first INAB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	10.6M
Net income (ttm)	-19M
EPS (ttm)	-$2.21
Shares out	9.8M
Volume	82,625
Beta	0.22
Price target	$6.25	+478.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -19M
EPS (ttm): -$2.21
Market cap: 10.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All INAB indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

USD

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001740279
Company name	IN8bio, Inc.
Country	United States
Country code	US
Cusip	45674E208
Employees	18
Employees Change	0%
Employees Change Percent	0
Enterprise value	$-9M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-30
Isin	US45674E2081
Last refreshed	2026-07-31
Market cap	$10.6M
Market cap category	Nano-Cap
Price	$1.08
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2836
Symbol	INAB
Website	https://in8bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-178.47%
FCF yield	-136.78%
P/B ratio	0.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19M
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Profit Per Employee	$-1.1M
ROA	-52.75
Roa5y	-49.51
ROCE	-78.73
ROE	-103.6
Roe5y	-103.7
ROIC	-56.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-50.93%
Cagr3y	-69.66%
EPS Growth Quarters	13
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$26.3M
Cash	$21.9M
Current Assets	$22.7M
Current Liabilities	$2.2M
Debt	$2.4M
Debt Equity	$0.1
Equity	$22.8M
Liabilities	$3.5M
Long Term Assets	$3.6M
Long Term Liabilities	$1.3M
Net Cash	$19.6M
Net Cash By Market Cap	$184
Net Cash Growth	157.18%
Net Debt Equity	$-0.86
Tangible Book Value	$22.8M
Tangible Book Value Per Share	$2.31
WACC	4.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.5
Net Working Capital	$-409,000
Quick ratio	10.17
Working Capital	$20.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-315.73%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-50.91%
200-day SMA	1.71
3Y total return	-97.21%
50-day SMA	1.43
50-day SMA vs 200-day SMA	50under200
All Time High	309.6
All Time High Change	-99.65%
All Time High Date	2021-08-11
All Time Low	0.96
All Time Low Change	12.45%
All Time Low Date	2026-07-30
ATR	0.08
Beta	0.22
Beta1y	2.81
Beta2y	1.96
Ch YTD	-53.85
High	1.08
High52	2.73
High52 Date	2026-01-16
High52ch	-60.44%
Low	0.96
Low52	0.96
Low52 Date	2026-07-30
Low52ch	12.45%
Ma50ch	-24.32%
Price vs 200-day SMA	-36.77%
RSI	26.99
RSI Monthly	26.06
RSI Weekly	35.36
Sharpe ratio	-0.54x
Sortino ratio	-0.75
Total Return	-315.73%
Tr YTD	-53.85
Tr1m	-24.48%
Tr1w	-9.24%
Tr3m	-28.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$5.5
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.42
Operating Income	$-19.5M
Price target	$6.25
Price Target Change	$479
Price Target Change Top	$409

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,211,156%
Float Percent	73.23%
Net Borrowing	-575,000
Shares Insiders	3.08%
Shares Institutions	24.78%
Shares Out	9,847,089
Shares Qo Q	174.13%
Shares Yo Y	315.73%
Short Float	0.29%
Short Ratio	0.46
Short Shares	0.21

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-17.3M
Adjusted OCF	-17,296,000
Average Volume	54,937.6x
Bv Per Share	2.31
CAPEX	$-9,000
Ch1m	-24.48
Ch1w	-9.24
Ch1y	-50.91
Ch3m	-28.48
Ch3y	-97.21
Ch6m	-46
Change	0.93%
Change From Open	2.37
Close	1.07
Days Gap	-1.4
Depreciation Amortization	1,628,000
Dollar Volume	89,235
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-19M
EBITDA	$-16.6M
EPS	$-2.21
F Score	2
FCF	$-14.5M
FCF EV Yield	162.49x
FCF Per Share	$-1.48
Financing CF	24,550,000
Fiscal Year End	December
Founded	2,016
Investing CF	-9,000
Ipr	-89.2
Iprfo	-99.64
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2025-06-06
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	1.68
Ma150ch	-35.52%
Ma20	1.29
Ma20ch	-16.28%
Net CF	10,004,000
Next Earnings Date	2026-08-10
Open	1.06
Optionable	No
Position In Range	100
Post Close	1.08
Postmarket Change Percent	1.76
Postmarket Price	$1.1
Ppne	3,254,000
Price Date	2026-07-30
Ptbv Ratio	0.47
Relative Volume	1.5x
Share Based Comp	2,759,000
Tr6m	-46%
Us State	New York
Volume	82,625

IN8bio, Inc. (INAB)

Coverage state: Market snapshot only — no published research

Generate the first INAB analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · INAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All INAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on INAB

Frequently asked questions